Antimicrobial Science

Antimicrobial Effectiveness (Non-Carrier)

Quantify antimicrobial performance in liquid, gel, or treated matrices using controlled inoculation, neutralization, and validated recovery.

We run suspension and matrix tests with defined contact times, enumerations, and statistics to support R&D, EPA-facing documentation, and formulation decisions.

ISO 17025ASTM E2315ASTM E1153EPA registrationReviewed 2026-05-16
Request a quoteSubmit a sample

Purpose & when to use

Antimicrobial Effectiveness (Non-Carrier) testing measures log10 reduction in a bulk product, formulation, gel, slurry, or extractable phase rather than on a fixed hard-surface carrier. Controlled inoculation, timed contact, neutralization, recovery, and enumeration are planned under ISO 17025 quality controls and aligned to ASTM E2315 or EPA registration needs. Use this service when:

  1. ASTM E2315 suspension screening ranks disinfectant formulations, actives, or preservatives before investing in larger EPA registration study matrices.
  2. EPA registration planning for antimicrobial liquids or sprays needs contact-time evidence before moving into carrier or use-site methods.
  3. ISO 17025 quality records are needed to compare gels, slurries, or treated extracts with validated neutralization and recovery controls.
  4. ASTM E1153 aligned recovery logic helps evaluate treated materials when extraction, adsorption, or viscosity could bias survivor counts.
  5. AOAC 961.02 residual narratives need non-carrier screening data before wear, drying, or hard-surface challenge studies are scoped.

Use non-carrier antimicrobial effectiveness testing when the first decision is whether the formulation or matrix has measurable kill potential. The study then defines the organism panel, contact time, neutralizer, and recovery workflow before Section 4 method selection.

Formulations and antimicrobial product types served

Non-carrier studies serve products where antimicrobial performance is evaluated in liquid, gel, spray, treated-material extract, or formulation matrix before EPA registration, ASTM, or AOAC-facing work expands.

  • DisinfectantsBulk liquid actives and blends
  • SpraysAntimicrobial trigger or aerosol products
  • GelsViscous products needing recovery checks
  • Treated materialsExtracts, eluates, and leachables
  • Industrial productsProcess fluids and additives

Instrumentation & measurement ranges

Platform selection follows organism panel, matrix behavior, endpoint timing, and the claim or screening decision the data supports.

15 sec – 24 hcontact time

Controlled inoculation and timed-contact workflow

Defined challenge preparation, mixing, exposure timing, temperature control, and endpoint transfer establish the core suspension or matrix-contact conditions for each product.

1 – 10 xdilution series

Neutralizer selection and verification

Candidate neutralizers are checked for antimicrobial stop activity and organism toxicity before efficacy results are interpreted, especially for actives with carryover risk.

1 – 8 LRVreduction

Recovery, dilution, and culture enumeration

Serial dilution, plating, incubation, and colony counting quantify survivors; recovery checks address adsorption, viscosity, soil load, and matrix interference.

20 – 40 Cincubation

Environmental incubation and control logging

Temperature, timing, organism handling, media lots, and incubation conditions are logged for each run so replicate statistics can be traced to protocol conditions.

Test method options

MethodStrengthsTradeoffAligned with
Suspension time-kill effectiveness (ASTM E2315 aligned)
  • ASTM E2315 supports repeatable formulation ranking across actives and contact times.
  • ISO 17025 controls document inoculum, timing, neutralization, and count calculations.
Suspension results may not predict performance on dried or porous use surfaces.
ASTM E2315ISO 17025
Matrix or gel effectiveness study (EPA registration aligned)
  • EPA registration planning gains product-specific contact-time data before carrier testing.
  • Validated recovery handles viscosity, adsorption, and active carryover in complex matrices.
Method development expands when product texture interferes with dilution or plating.
EPA registrationISO 17025
Interference and soil-load robustness (ASTM E1153 aligned)
  • ASTM E1153 recovery logic helps separate product kill from extraction bias.
  • Soils, hard water, or stressors reveal sensitivity before claim studies expand.
Added controls increase sample count and require predefined acceptance criteria.
ASTM E1153ISO 17025
Residual-screening comparison (AOAC 961.02 aligned)
  • AOAC 961.02 framing informs later residual or wear-study design choices.
  • Side-by-side panels compare actives, binders, and contact times efficiently.
Screening data still needs carrier confirmation for many hard-surface claims.
AOAC 961.02EPA registration

Setup configurations

Non-carrier antimicrobial studies are scoped around product matrix, target organisms, contact time, neutralization chemistry, and recovery behavior. We define inoculum target, exposure conditions, soils or interferents, replicate plan, control set, and decision threshold before testing so the log-reduction result maps to the customer's regulatory or formulation question.

Sample matrix

Liquid, gel, slurry, spray product, treated-material extract, or process fluid documented by active, lot, concentration, and handling conditions.

Exposure profile

Contact times, temperature, organism panel, soil load, hard-water condition, and endpoint transfer sequence fixed before inoculation begins.

Media & handling

Neutralizer, dilution media, plating method, incubation conditions, and matrix blanks selected to avoid antimicrobial carryover or recovery suppression.

Sample numbers

Replicates, untreated controls, neutralizer controls, toxicity controls, growth controls, and matrix blanks sized to the expected reduction target.

Chain of custody

Sample receipt, storage, lot identity, preparation notes, timing records, and deviations documented from intake through final enumeration.

Methods anchored to the standards that matter

These quality chips separate the accredited laboratory system from aligned antimicrobial method and EPA registration frames. Each item mirrors the hero accreditation labels used on this leaf.

  • ISO 17025AccreditedLaboratory competence, traceability, documented methods, and uncertainty controls.
  • ASTM E2315AlignedSuspension time-kill method anchor for liquid antimicrobial products.
  • ASTM E1153AlignedRecovery and carrier-style logic for surface antimicrobial measurements.
  • EPA registrationAlignedPerformance-substantiation frame for antimicrobial product claims.

Key data outputs & reporting

Non-carrier antimicrobial effectiveness studies deliver log-reduction results by organism, matrix, contact time, and condition, with recovery and neutralization controls shown next to the efficacy outcome. Reports emphasize whether observed kill is attributable to product activity rather than carryover, poor extraction, or matrix interference. Comparison tables can add formulation, active-level, soil-load, or contact-time overlays when those decisions drive the next test stage.

Primary outputs

  • Log10 reduction versus growth or untreated controls for each organism, contact time, matrix, and product condition.
  • Pass / fail calls against predefined criteria when the protocol includes a decision threshold.
  • Neutralization effectiveness and toxicity-control summaries documenting whether antimicrobial action stopped at the endpoint.
  • Recovery validation results for viscous, adsorptive, soil-loaded, or treated-material matrices.
  • Replicate statistics including mean, SD, CV, and flagged deviations where the design supports comparison.

Deliverables

#FormatContents
01PDF reportMethods, controls, log-reduction tables, QA / QC notes, and interpretation limits.
02CSV / XLSX datasetsRaw counts, dilution factors, calculations, recovery checks, and replicate statistics.
03FiguresTime-to-kill curves, organism overlays, and condition comparisons for technical review.

QA / QC & data integrity

Antimicrobial effectiveness data are only interpretable when challenge preparation, contact timing, neutralization, recovery, and enumeration are controlled together. Each study includes documented controls under the ISO 17025 quality system, with recovery and neutralization evidence reviewed before log-reduction results are finalized for screening, comparison, or EPA-facing substantiation.

Growth controls and inoculum confirmations verify the microbial challenge was viable and within the target range.

Neutralization effectiveness and toxicity controls confirm the stop solution works without suppressing organism recovery.

Matrix blanks and contamination checks separate product interference from microbial survival.

Recovery validation documents extraction or dilution performance for viscous, adsorptive, or treated-material matrices.

Replicate calculations report mean, SD, and CV where the design supports quantitative comparison.

Chain-of-custody, timing logs, media lots, and deviations are retained with the final data package.

Why ARE Labs

ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.

Reviewed byJamie Balarashti (25 yrs - cascade & inhalation methods) - Weston Schaper (7 yrs - real-time sizing & nanoparticle work)
17025Accredited testing
900+Studies Performed
17+Years in operation
300+Clients supported

Common questions

These questions come up when antimicrobial-product teams, treated-material developers, formulation scientists, and consumer-product groups scope non-carrier effectiveness studies. They cover EPA-facing use, neutralization, recovery validation, soils, replicates, deliverables, and when to move into carrier methods. The answers below are starting points; reach out if your product matrix, organism panel, or claim path does not match the examples here.

Q.Is this an EPA registration claim test?
A.Usually it is a screening or substantiation study, not the final claim test. Non-carrier data can support EPA-facing decisions by selecting contact times, actives, or formulations before carrier-based claim methods are run.
Q.Why does neutralization matter for antimicrobial testing?
A.Neutralization stops the antimicrobial at the planned endpoint. Without a proven stop step, survivors may keep dying during dilution or plating, making the product look more effective than it was at the contact time.
Q.Can you test gels, soils, or hard-water conditions?
A.Yes. We can scope viscous matrices, soil loads, hard water, or interfering substances when they match the product's intended use. Each added condition gets controls for recovery, neutralization, and interpretation.
Q.How many replicates are typical?
A.Replicate count depends on expected variability, organism panel, and decision threshold. We usually include replicates plus growth controls, neutralizer controls, toxicity controls, and matrix blanks for each major condition.
Q.What do we receive after the study?
A.You receive a PDF report plus CSV or XLSX tables with raw counts, dilution factors, calculations, controls, recovery data, and log10 reductions. Figures can show time-to-kill curves or condition overlays.

Standards & guidance

Antimicrobial effectiveness studies at ARE Labs are planned around laboratory competence, suspension time-kill methods, carrier-style recovery logic, residual-use context, and EPA registration performance expectations. ISO 17025 is the accredited laboratory anchor. ASTM E2315, ASTM E1153, AOAC 961.02, and EPA registration are aligned frames applied where the product, matrix, and claim language support them.

QA & Regulatory - Accredited

ISO 17025

Testing-laboratory competence, documented methods, traceability, and quality-system controlsView standard ->Surface Antimicrobial - Aligned

ASTM E2315

Suspension time-kill procedure for evaluating antimicrobial activity in liquid exposure systemsView standard ->Surface Antimicrobial - Aligned

ASTM E1153

Quantitative antimicrobial measurement and recovery logic for nonporous surface contextsView standard ->Surface Antimicrobial - Aligned

AOAC 961.02

Residual-use context for treated-product and disinfectant performance narrativesView standard ->Antimicrobial Claims - Aligned

EPA registration

Performance-substantiation expectations for antimicrobial product registration and claim supportView standard ->

Related services & devices

Service

Surface Carrier-Based Surface Efficacy

Carrier studies can follow non-carrier screening when the claim must prove performance on a defined hard surface.Read more ->Devices

Surface Antimicrobial Products

Disinfectants, treated materials, and antimicrobial devices use non-carrier data to narrow active levels and contact times.Read more ->Service

Time-Kill Kinetics (Surface / Liquid)

Time-kill studies expand promising formulations into richer contact-time curves across organisms and conditions.Read more ->Devices

Aerosol and Trigger Sprays

Spray products may need formulation effectiveness data before droplet, deposition, or carrier efficacy studies.Read more ->